Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
11.38
-0.02 (-0.18%)
Apr 10, 2026, 3:04 PM CST
SHE:000590 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 177.71 | 177.29 | 189.77 | 235.42 | 250.68 |
Trading Asset Securities | - | - | - | 25.11 | 75.15 |
Cash & Short-Term Investments | 177.71 | 177.29 | 189.77 | 260.53 | 325.83 |
Cash Growth | 0.24% | -6.58% | -27.16% | -20.04% | -4.99% |
Accounts Receivable | 67.69 | 103.15 | 154.4 | 117.16 | 124.81 |
Other Receivables | 16.14 | 90.28 | 60.51 | 30.11 | 6 |
Receivables | 83.83 | 193.43 | 214.91 | 147.27 | 130.82 |
Inventory | 109.57 | 124.78 | 130.09 | 118.22 | 86.59 |
Prepaid Expenses | - | 2.32 | - | 0.03 | 0 |
Other Current Assets | 7.76 | 2.17 | 4.79 | 3.06 | 10.65 |
Total Current Assets | 378.87 | 499.99 | 539.55 | 529.11 | 553.88 |
Property, Plant & Equipment | 308.31 | 312.66 | 293.81 | 289.75 | 240.89 |
Long-Term Investments | 23.02 | 20.03 | 20.9 | 19 | 19 |
Goodwill | - | 13.2 | 131.64 | 137.14 | - |
Other Intangible Assets | 123.45 | 131.06 | 132.33 | 157.44 | 133.69 |
Long-Term Accounts Receivable | - | 3.09 | 5.05 | 7.42 | - |
Long-Term Deferred Tax Assets | 14.9 | 8.18 | 4.09 | 5.23 | 4.97 |
Long-Term Deferred Charges | 7.4 | 6.29 | 3.32 | 2.93 | 1.82 |
Other Long-Term Assets | 33.52 | 18.92 | 20.42 | 19 | 13.57 |
Total Assets | 889.47 | 1,013 | 1,151 | 1,167 | 967.83 |
Accounts Payable | 64.07 | 73.24 | 83.55 | 64.01 | 41.67 |
Accrued Expenses | 35.62 | 43.88 | 46.62 | 50.8 | 40.37 |
Short-Term Debt | - | 0.75 | - | 25.82 | - |
Current Portion of Long-Term Debt | 21.16 | 11.01 | 10 | 10.1 | - |
Current Portion of Leases | - | 2.94 | 2.36 | 2.69 | 3 |
Current Income Taxes Payable | 3.48 | 6.8 | 2.3 | 3.4 | 3.85 |
Current Unearned Revenue | 36.15 | 45.33 | 50.12 | 56.13 | 53.42 |
Other Current Liabilities | 40.85 | 52.31 | 53.82 | 58.45 | 44.68 |
Total Current Liabilities | 201.33 | 236.26 | 248.77 | 271.42 | 186.98 |
Long-Term Debt | 50 | 82.22 | 80 | 90 | - |
Long-Term Leases | 0.81 | 1.49 | 3.07 | 5.18 | 5.59 |
Long-Term Unearned Revenue | 44.98 | 43.99 | 42.44 | 44.37 | 46.29 |
Long-Term Deferred Tax Liabilities | 5.81 | 5.15 | 5.91 | 7.47 | 0.02 |
Other Long-Term Liabilities | 37.05 | 43.07 | 42.72 | 46.09 | 46.62 |
Total Liabilities | 339.98 | 412.18 | 422.92 | 464.53 | 285.5 |
Common Stock | 239.47 | 239.47 | 239.47 | 239.47 | 239.47 |
Additional Paid-In Capital | 473.95 | 474.06 | 474.06 | 474.06 | 474.06 |
Retained Earnings | -165.81 | -115.29 | 10.18 | -15.06 | -33.21 |
Total Common Equity | 547.61 | 598.25 | 723.72 | 698.47 | 680.32 |
Minority Interest | 1.87 | 2.99 | 4.49 | 4.03 | 2 |
Shareholders' Equity | 549.49 | 601.23 | 728.2 | 702.5 | 682.32 |
Total Liabilities & Equity | 889.47 | 1,013 | 1,151 | 1,167 | 967.83 |
Total Debt | 71.97 | 98.42 | 95.43 | 133.79 | 8.58 |
Net Cash (Debt) | 105.74 | 78.87 | 94.34 | 126.74 | 317.24 |
Net Cash Growth | 34.07% | -16.40% | -25.56% | -60.05% | -6.13% |
Net Cash Per Share | 0.44 | 0.33 | 0.39 | 0.53 | 1.32 |
Filing Date Shares Outstanding | 239.38 | 239.47 | 239.47 | 239.47 | 239.47 |
Total Common Shares Outstanding | 239.38 | 239.47 | 239.47 | 239.47 | 239.47 |
Working Capital | 177.54 | 263.73 | 290.78 | 257.69 | 366.9 |
Book Value Per Share | 2.29 | 2.50 | 3.02 | 2.92 | 2.84 |
Tangible Book Value | 424.17 | 453.98 | 459.75 | 403.89 | 546.63 |
Tangible Book Value Per Share | 1.77 | 1.90 | 1.92 | 1.69 | 2.28 |
Buildings | - | 267.95 | 247.28 | 243.93 | 198.81 |
Machinery | - | 220.21 | 197.31 | 189.09 | 174.95 |
Construction In Progress | - | 8.81 | 23.83 | 15.21 | 4.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.